Research into nanoparticle delivery of cancer drugs receives CPRIT funding

A drug-delivery system that targets and destroys ovarian cancer cells is one step closer to improving the outcome for women diagnosed with the often deadly disease.

A $742,000 Cancer Prevention and Research Institute of Texas (CPRIT) grant will be used to strengthen research on the use of "good cholesterol" nanoparticles that can selectively shrink or destroy ovarian cancer tumors. The funding is the first commercial CPRIT grant that UNT Health Science Center has received.

The grant, which is being shared with the University of Texas M.D. Anderson Cancer Center, will help expedite the goal of launching human clinical trials involving the use of nanoparticles to fight ovarian cancer, said Andres Lacko, PhD, Professor of Integrative Physiology & Anatomy and Pediatrics.

Dr. Lacko and Anil Sood, MD, of M.D. Anderson have been working together to develop better ways to destroy malignant tumors. They jointly developed the approach using nanoparticles for cancer therapeutics, which builds on Dr. Lacko’s original research utilizing synthetic high-density lipoprotein’s (HDL) potential for cancer-drug delivery.

"Ovarian cancer is such a tough disease to treat," Dr. Lacko said. "We are hopeful this will prove to be a highly effective way to treat this disease in combination with other therapies."

For 14 years, Dr. Lacko has studied drug-carrying synthetic "good" cholesterol nanoparticles called "rHDL," which can function like a Trojan horse. Cancer cells consume large amounts of cholesterol, so they can be fooled when anti-cancer drugs are placed inside the rHDL particles.

The unique drug-delivery method makes it possible to bypass most normal cells, which don’t need as much cholesterol, and go straight to the cancer cells, thus sparing patients from experiencing the harmful effects of chemotherapy.

The research also is being applied to potentially treat breast, prostate and other cancers.

Research on another phase of the nanoparticle development, based on the same principles, recently led to a license agreement with a Silicon Valley company that could lead to the manufacture of the nanoparticles for human trials, Dr. Lacko said.

"We hope to attract investors and, in the long run, move toward manufacturing this formulation," Dr. Lacko said. "UNTHSC is half owner of the patents involving the rHDL nanoparticles and will benefit greatly if this approach is a clinical/commercial success."

Recent News

Kari Northeim
  • Our People
|Sep 28, 2023

HSC’s Dr. Kari Northeim and Parker County collaborators awarded SAMHSA grant for rural EMS training and education

  Dr. Kari Northeim, School of Public Health assistant professor of population and community health at The University of North Texas Health Science Center at Fort Worth, has been awarded the SAMHSA Rural EMS Training and Education grant in conjunction with HSC community partners, Parke...
Graci Finco
  • Research
|Sep 28, 2023

SBS researchers publish innovative study in Nature Scientific Reports 

People with leg amputations, including those with diabetes, run the risk of overuse injuries like osteoarthritis, muscle atrophy or bone breaks in their intact limbs.   Now, new research is quantifying the impacts of amputations and diabetes, a leading cause of amputation, on those overuse ...
Frank Filipetto Cropped For Social
  • On Campus
|Sep 28, 2023

HSC’s Texas College of Osteopathic Medicine to host symposium on ‘Creating Change in Health Care Delivery’

Americans have soured on the U.S. health care system, according to a Gallup poll taken earlier this year. Most of those surveyed rate health care quality as subpar, including 31% saying it is “only fair” and 21% — a new high — calling it “poor.” The U.S. ranked nearly last compared w...
Tarri Wyre
  • On Campus
|Sep 26, 2023

SaferCare Texas empowers Community Health Workers to complete HSC Mental Wellness microcredential

Tarri Wyre saw the growing need to expand her mental health education. The community health worker and ambulatory care manager for Memorial Hermann Health in Houston turned to the Mental Wellness microcredential, offered by The University of North Texas Health Science Center at Fort Worth’s SaferC...